Menu
Recruiting NCT05857813

Social Skills Training Group Effectiveness in Adolescents With Autism Spectrum Disorder

No phase Interventional Autism Spectrum Disorder

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Program for the Education and Enrichment of Relational Skills (PEERS®).
Who it may be relevant to
Registry conditions: Autism Spectrum Disorder. Basic parameters: 11 years — 20 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Taiwan
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Establishment of Social Skills Training Group in Adolescents With Autism Spectrum Disorder and Effectiveness Analysis

Overview

Autism spectrum disorders (ASD) is a neurodevelopmental disorder characterized by persistent deficits in social communication and social interaction across multiple contexts, and the presence of restricted, repetitive behavior and interests, affecting 1 in 68 children. Although atypical social deficits onset in early childhood, their social relationships with peers may remain a challenge or even worsen for individuals with ASD throughout the school years and beyond, as social contexts increase in complexity and pose higher social expectations.

Interventions

  • Behavioral Program for the Education and Enrichment of Relational Skills (PEERS®)
    developed at the University of California, Los Angeles (E. A. Laugeson \& F. Frankel, 2010). This is a parent-assisted, manualized social skills training program that addresses crucial areas of social functioning for adolescents. Psycho-education and cognitive-behavioral therapy techniques are employed to help adolescents develop ecologically valid skills for making and maintaining friendships.

Primary outcome measures

  • Autism Diagnostic Interview-Revised (ADI-R) [Time frame: 7 weeks]
  • The Autism Diagnostic Observation Schedule (ADOS) [Time frame: 7 weeks]
  • Autism Spectrum Quotient (AQ) [Time frame: 7 weeks]
  • Friendship Quality Scale (FQS) [Time frame: 7 weeks]
  • The Assessing Emotions Scale (AES) [Time frame: 7 weeks]
  • Social Responsiveness Scale (SRS) [Time frame: 7 weeks]
  • Social Adjustment Inventory for Children and Adolescents (SAICA) [Time frame: 7 weeks]
  • Quality of Play Questionnaire (QPQ) [Time frame: 7 weeks]
  • Test of Adolescents Social Skills Knowledge (TASSK) [Time frame: 7 weeks]
  • Empathy Quotient (EQ) [Time frame: 7 weeks]

Eligibility criteria

Inclusion criteria

  • aged 11-20 years, currently enrolled in school between the sixth grade of elementary school and the third year of high school
  • with a clinical diagnosis of ASD from a licensed mental health or medical professional based on DSM-5
  • experiencing social difficulties as reported by parents in a structured intake interview
  • scored ≧ 26 on the caregiver-reported Autism Spectrum Quotient (AQ), indicating clinical impairment associated with ASD
  • demonstrating verbal fluency in Chinese
  • with a full-scale IQ > 70 on WAIS-IV
  • with motivation to participate in the intervention;
  • with a caregiver who was fluent in Chinese and willing to participate as a social coach in the study.

Exclusion criteria

  • a history of major mental illness (e.g., bipolar affective disorder, schizophrenia, or psychosis) or neurological diseases that might hinder participation in the treatment
  • visual impairment and/or hearing impairment that would preclude participation in group-based social activities.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Treatment

Study locations

Taiwan · 1 center
  • National Taiwan University Hospital — Taipei

Identifiers

NCT: NCT05857813 · 202109033RIND

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗